Axsome Therapeutics (AXSM) Goodwill & Intangibles (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Goodwill & Intangibles data on file, last reported at $50.9 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 11.12% year-over-year to $50.9 million; the trailing twelve-month figure through Mar 2026 stood at $50.9 million (down 11.12% YoY), and the FY2025 full-year result was $75.8 million, up 28.61% from the prior year.
• Goodwill & Intangibles slipped to $50.9 million in Q1 2026, from $75.8 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $75.8 million in Q4 2023 to a low of $50.9 million in Q1 2026.
• A 5-year average of $65.7 million and a median of $65.3 million in 2023 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles soared 33.86% in 2024 and dropped 28.54% in 2025, its largest moves.
• Tracing AXSM's Goodwill & Intangibles over 5 years: stood at $74.1 million in 2022, then rose by 2.28% to $75.8 million in 2023, then fell by 22.25% to $58.9 million in 2024, then advanced by 28.61% to $75.8 million in 2025, then tumbled by 32.79% to $50.9 million in 2026.
• Business Quant data shows AXSM's Goodwill & Intangibles at $50.9 million in Q1 2026, $75.8 million in Q4 2025, and $54.2 million in Q3 2025.